Hereditary Testing Market Size, Share, Trends, Industry Analysis Report: By Technology (Cytogenetic, Biochemical, and Molecular Testing), Sample Type, Disease Type, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
Description
The hereditary testing market size is expected to reach USD 17.13 billion by 2034, according to a new study by Polaris Market Research. The report “Hereditary Testing Market Size, Share, Trends, Industry Analysis Report: By Technology (Cytogenetic, Biochemical, and Molecular Testing), Sample Type, Disease Type, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Hereditary testing is a genetic diagnostic procedure used to identify inherited mutations that may contribute to disease development. It enables early detection, risk assessment, and personalized treatment planning. The hereditary testing market is experiencing significant growth due to advancements in next-generation sequencing, increasing awareness of genetic disorders, and rising demand for precision medicine.
Opportunities in the market are expanding with the integration of artificial intelligence for improved genetic analysis and the growing adoption of direct-to-consumer genetic testing. Key trends include the increasing focus on hereditary cancer testing, the expansion of noninvasive prenatal testing, and regulatory developments supporting hereditary testing market expansion. Rising healthcare expenditures, improved accessibility to genetic testing, and the global emphasis on preventive healthcare solutions further drive the market.
Hereditary Testing Market Report Highlights
Molecular testing held the largest hereditary testing market share in 2024 due to its high accuracy and widespread adoption in genetic analysis.
The blood segment dominated the market as it is widely used for genetic testing due to its ease of collection and reliability. Saliva-based testing is witnessing the fastest growth due to the increasing demand for non-invasive and at-home genetic testing solutions.
North America dominated the hereditary testing market in 2024 due to well-established healthcare infrastructure, strong regulatory frameworks, and high adoption of genetic testing. Asia Pacific is the fastest-growing region, driven by increasing healthcare investments, rising awareness of genetic disorders, and expanding genetic testing services in emerging economies.
Some of the major players in the market include CENTOGENE N.V., F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Illumina, Inc., Laboratory Corporation of America Holdings, MedGenome Inc., Myriad Genetics, Inc., Natera, Inc., Quest Diagnostics Incorporated, SOPHiA GENETICS SA, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, WuXi NextCODE Genomics, Inc.
Polaris Market Research has segmented hereditary testing market report on basis of technology, sample type, disease type, and region:
By Technology Outlook (Revenue-USD Billion, 2020–2034)
Cytogenetic
Biochemical
Molecular Testing
By Sample Type Outlook (Revenue-USD Billion, 2020–2034)
Tumor Tissue
Bone Marrow
Saliva
Blood
Others
By Disease Type Outlook (Revenue-USD Billion, 2020–2034)
Hereditary Cancer
Lung Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Breast Cancer
Melanoma
Sarcoma
Others
By Regional Outlook (Revenue-USD Billion, 2020–2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Hereditary testing is a genetic diagnostic procedure used to identify inherited mutations that may contribute to disease development. It enables early detection, risk assessment, and personalized treatment planning. The hereditary testing market is experiencing significant growth due to advancements in next-generation sequencing, increasing awareness of genetic disorders, and rising demand for precision medicine.
Opportunities in the market are expanding with the integration of artificial intelligence for improved genetic analysis and the growing adoption of direct-to-consumer genetic testing. Key trends include the increasing focus on hereditary cancer testing, the expansion of noninvasive prenatal testing, and regulatory developments supporting hereditary testing market expansion. Rising healthcare expenditures, improved accessibility to genetic testing, and the global emphasis on preventive healthcare solutions further drive the market.
Hereditary Testing Market Report Highlights
Molecular testing held the largest hereditary testing market share in 2024 due to its high accuracy and widespread adoption in genetic analysis.
The blood segment dominated the market as it is widely used for genetic testing due to its ease of collection and reliability. Saliva-based testing is witnessing the fastest growth due to the increasing demand for non-invasive and at-home genetic testing solutions.
North America dominated the hereditary testing market in 2024 due to well-established healthcare infrastructure, strong regulatory frameworks, and high adoption of genetic testing. Asia Pacific is the fastest-growing region, driven by increasing healthcare investments, rising awareness of genetic disorders, and expanding genetic testing services in emerging economies.
Some of the major players in the market include CENTOGENE N.V., F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Illumina, Inc., Laboratory Corporation of America Holdings, MedGenome Inc., Myriad Genetics, Inc., Natera, Inc., Quest Diagnostics Incorporated, SOPHiA GENETICS SA, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, WuXi NextCODE Genomics, Inc.
Polaris Market Research has segmented hereditary testing market report on basis of technology, sample type, disease type, and region:
By Technology Outlook (Revenue-USD Billion, 2020–2034)
Cytogenetic
Biochemical
Molecular Testing
By Sample Type Outlook (Revenue-USD Billion, 2020–2034)
Tumor Tissue
Bone Marrow
Saliva
Blood
Others
By Disease Type Outlook (Revenue-USD Billion, 2020–2034)
Hereditary Cancer
Lung Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Breast Cancer
Melanoma
Sarcoma
Others
By Regional Outlook (Revenue-USD Billion, 2020–2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
118 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
- 4. Global Hereditary Testing Market Insights
- 4.1. Hereditary Testing Market – Market Snapshot
- 4.2. Hereditary Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Advancements in Genetic Testing Technologies
- 4.2.1.2. Increasing Awareness and Acceptance of Personalized Medicine
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Ethical and privacy concerns
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Hereditary Testing Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Hereditary Testing Market, by Technology
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 5.3. Cytogenetic
- 5.3.1. Global Hereditary Testing Market, by Cytogenetic, by Region, 2020–2034 (USD Billion)
- 5.4. Biochemical
- 5.4.1. Global Hereditary Testing Market, by Biochemical, by Region, 2020–2034 (USD Billion)
- 5.5. Molecular Testing
- 5.5.1. Global Hereditary Testing Market, by Molecular Testing, by Region, 2020–2034 (USD Billion)
- 6. Global Hereditary Testing Market, by Sample Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 6.3. Tumor Tissue
- 6.3.1. Global Hereditary Testing Market, by Tumor Tissue, by Region, 2020–2034 (USD Billion)
- 6.4. Bone Marrow
- 6.4.1. Global Hereditary Testing Market, by Bone Marrow, by Region, 2020–2034 (USD Billion)
- 6.5. Saliva
- 6.5.1. Global Hereditary Testing Market, by Saliva, by Region, 2020–2034 (USD Billion)
- 6.6. Blood
- 6.6.1. Global Hereditary Testing Market, by Blood, by Region, 2020–2034 (USD Billion)
- 6.7. Other Sample Types
- 6.7.1. Global Hereditary Testing Market, by Other Sample Types, by Region, 2020–2034 (USD Billion)
- 7. Global Hereditary Testing Market, by Disease Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 7.3. Hereditary Cancer
- 7.3.1. Global Hereditary Testing Market, by Hereditary Cancer, by Region, 2020–2034 (USD Billion)
- 7.4. Lung Cancer
- 7.4.1. Global Hereditary Testing Market, by Lung Cancer, by Region, 2020–2034 (USD Billion)
- 7.5. Colorectal Cancer
- 7.5.1. Global Hereditary Testing Market, by Colorectal Cancer, by Region, 2020–2034 (USD Billion)
- 7.6. Ovarian Cancer
- 7.6.1. Global Hereditary Testing Market, by Ovarian Cancer, by Region, 2020–2034 (USD Billion)
- 7.7. Prostate Cancer
- 7.7.1. Global Hereditary Testing Market, by Prostate Cancer, by Region, 2020–2034 (USD Billion)
- 7.8. Melanoma
- 7.8.1. Global Hereditary Testing Market, by Melanoma, by Region, 2020–2034 (USD Billion)
- 7.9. Sarcoma
- 7.9.1. Global Hereditary Testing Market, by Sarcoma, by Region, 2020–2034 (USD Billion)
- 7.10. Others
- 7.10.1. Global Hereditary Testing Market, by Others, by Region, 2020–2034 (USD Billion)
- 8. Global Hereditary Testing Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Hereditary Testing Market Assessment, By Geography, 2020–2034 (USD Billion)
- 8.3. Hereditary Testing Market – North America
- 8.3.1. North America: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.3.2. North America: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.3.3. North America: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.3.4. Hereditary Testing Market – U.S.
- 8.3.4.1. U.S.: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.3.4.2. U.S.: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.3.4.3. U.S.: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.3.5. Hereditary Testing Market – Canada
- 8.3.5.1. Canada: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.3.5.2. Canada: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.3.5.3. Canada: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.4. Hereditary Testing Market – Europe
- 8.4.1. Europe: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.4.2. Europe: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.4.3. Europe: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.4.4. Hereditary Testing Market – UK
- 8.4.4.1. UK: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.4.4.2. UK: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.4.4.3. UK: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.4.5. Hereditary Testing Market – France
- 8.4.5.1. France: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.4.5.2. France: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.4.5.3. France: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.4.6. Hereditary Testing Market – Germany
- 8.4.6.1. Germany: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.4.6.2. Germany: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.4.6.3. Germany: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.4.7. Hereditary Testing Market – Italy
- 8.4.7.1. Italy: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.4.7.2. Italy: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.4.7.3. Italy: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.4.8. Hereditary Testing Market – Spain
- 8.4.8.1. Spain: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.4.8.2. Spain: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.4.8.3. Spain: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.4.9. Hereditary Testing Market – Netherlands
- 8.4.9.1. Netherlands: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.4.9.2. Netherlands: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.4.9.3. Netherlands: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.4.10. Hereditary Testing Market – Russia
- 8.4.10.1. Russia: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.4.10.2. Russia: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.4.10.3. Russia: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.4.11. Hereditary Testing Market – Rest of Europe
- 8.4.11.1. Rest of Europe: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.5. Hereditary Testing Market – Asia Pacific
- 8.5.1. Asia Pacific: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.5.2. Asia Pacific: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.5.3. Asia Pacific: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.5.4. Hereditary Testing Market – China
- 8.5.4.1. China: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.5.4.2. China: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.5.4.3. China: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.5.5. Hereditary Testing Market – India
- 8.5.5.1. India: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.5.5.2. India: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.5.5.3. India: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.5.6. Hereditary Testing Market – Malaysia
- 8.5.6.1. Malaysia: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.5.6.2. Malaysia: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.5.6.3. Malaysia: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.5.7. Hereditary Testing Market – Japan
- 8.5.7.1. Japan: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.5.7.2. Japan: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.5.7.3. Japan: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.5.8. Hereditary Testing Market – Indonesia
- 8.5.8.1. Indonesia: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.5.8.2. Indonesia: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.5.8.3. Indonesia: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.5.9. Hereditary Testing Market – South Korea
- 8.5.9.1. South Korea: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.5.9.2. South Korea: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.5.9.3. South Korea: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.5.10. Hereditary Testing Market – Australia
- 8.5.10.1. Australia: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.5.10.2. Australia: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.5.10.3. Australia: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.5.11. Hereditary Testing Market – Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.6. Hereditary Testing Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.6.2. Middle East & Africa: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.6.3. Middle East & Africa: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.6.4. Hereditary Testing Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.6.5. Hereditary Testing Market – UAE
- 8.6.5.1. UAE: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.6.5.2. UAE: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.6.5.3. UAE: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.6.6. Hereditary Testing Market – Israel
- 8.6.6.1. Israel: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.6.6.2. Israel: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.6.6.3. Israel: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.6.7. Hereditary Testing Market – South Africa
- 8.6.7.1. South Africa: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.6.7.2. South Africa: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.6.7.3. South Africa: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.6.8. Hereditary Testing Market – Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.7. Hereditary Testing Market – Latin America
- 8.7.1. Latin America: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.7.2. Latin America: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.7.3. Latin America: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.7.4. Hereditary Testing Market – Mexico
- 8.7.4.1. Mexico: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.7.4.2. Mexico: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.7.4.3. Mexico: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.7.5. Hereditary Testing Market – Brazil
- 8.7.5.1. Brazil: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.7.5.2. Brazil: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.7.5.3. Brazil: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.7.6. Hereditary Testing Market – Argentina
- 8.7.6.1. Argentina: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.7.6.2. Argentina: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.7.6.3. Argentina: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 8.7.7. Hereditary Testing Market – Rest of Latin America
- 8.7.7.1. Rest of Latin America: Hereditary Testing Market, by Technology, 2020–2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Hereditary Testing Market, by Sample Type, 2020–2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Hereditary Testing Market, by Disease Type, 2020–2034 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. Agilent Technologies, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. CENTOGENE N.V.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. CooperSurgical, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. F. Hoffmann-La Roche Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Fulgent Genetics, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Illumina, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Laboratory Corporation of America Holdings
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. MedGenome Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Myriad Genetics, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Natera, Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
